GeraldVNaccarelliMD

PubMed

• A Multimorbidity-Based, Risk-Stratified Reanalysis of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Trial.
  Mohammed Ruzieh, John Mandrola, Anne-Marie Dyer, Vernon M. Chinchilli, Gerald V. Naccarelli, Andrew Foy> ;Drugs & Aging. 2020 Sep 16
• Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation.
  Goehring, E. L., Bohn, R. L., Pezzullo, J., Tave, A. K., Jones, J. K., Bozzi, S., Tamayo, R. C., Sicignano, N., Naccarelli, G. V.> ;The American journal of cardiology. 2020 Aug 31
• Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF).
  Madhavan, M., Holmes, D. N., Piccini, J. P., Freeman, J. V., Fonarow, G. C., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Pieper, K., Peterson, E. D., Chan, P. S., All...> ;The American journal of cardiology. 2020 Aug 23
• Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies.
  Naccarelli, G. V., Bhatt, D. L., Camm, A. J., Le Heuzey, J., Lombardi, F., Tamargo, J., Martinez, J., Naditch-Brûlé, L.> ;Journal of cardiovascular pharmacology and therapeutics. 2020 Jun 6
• Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry.
  Sherwood, M. W., Piccini, J. P., Holmes, D. N., Pieper, K. S., Steinberg, B. A., Fonarow, G. C., Allen, L. A., Naccarelli, G. V., Kowey, P. R., Gersh, B. J., Mahaffey,...> ;Circulation. Cardiovascular interventions. 2020 May 16
• Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions.
  Ali-Ahmed, F., Pieper, K., North, R., Allen, L. A., Chan, P. S., Ezekowitz, M. D., Fonarow, G. C., Freeman, J. V., Go, A. S., Gersh, B. J., Kowey, P. R., Mahaffey, K. ...> ;European heart journal. Quality of care & clinical outcomes. 2020 May 12
• Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
  Thind, M., Crijns, H. J., Naccarelli, G. V., Reiffel, J. A., Genti, V. C., Wieloch, M., Koren, A., Kowey, P. R.> ;Journal of cardiovascular electrophysiology. 2020 Feb 23
• Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation.
  Inohara, T., Holmes, D. N., Pieper, K., Blanco, R. G., Allen, L. A., Fonarow, G. C., Gersh, B. J., Hylek, E. M., Ezekowitz, M. D., Kowey, P. R., Reiffel, J. A., Naccar...> ;Heart (British Cardiac Society). 2020 Jan 9
• Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.
  Pokorney, S. D., Holmes, D. N., Shrader, P., Thomas, L., Fonarow, G. C., Mahaffey, K. W., Gersh, B. J., Kowey, P. R., Naccarelli, G. V., Freeman, J. V., Singer, D. E.,...> ;American heart journal. 2019 Dec 10
• Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.
  Loring, Z., Shrader, P., Allen, L. A., Blanco, R., Chan, P. S., Ezekowitz, M. D., Fonarow, G. C., Freeman, J. V., Gersh, B. J., Mahaffey, K. W., Naccarelli, G. V., Pie...> ;American heart journal. 2019 Nov 12
• Risk Factors for Symptomatic Atrial Fibrillation-Analysis of an Outpatient Database.
  Volgman, A. S., Dunn, P., Sundberg, A., Conard, S., Chakravarty, P., Htway, Z., Waldo, A., Albert, C., Turakhia, M. P., Naccarelli, G. V.> ;Journal of atrial fibrillation. 2019 Nov 7
• Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo.
  Ruzieh, M., Moroi, M. K., Aboujamous, N. M., Ghahramani, M., Naccarelli, G. V., Mandrola, J., Foy, A. J.> ;The American journal of cardiology. 2019 Oct 28
• Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
  Pokorney, S. D., Holmes, D. N., Thomas, L., Fonarow, G. C., Kowey, P. R., Reiffel, J. A., Singer, D. E., Freeman, J. V., Gersh, B. J., Mahaffey, K. W., Hylek, E. M., N...> ;JAMA cardiology. 2019 Jul 4
• Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fib...
  Taku Inohara, Peter Shrader, Karen S. Pieper, Rosalia Blanco, Larry A. Allen, Gregg C. Fonarow, Bernard J. Gersh, Alan S. Go, Michael D. Ezekowitz, Peter R. Kowey, Jam...> ;American Heart Journal. 2019 Jul 1
• Association of sex and atrial fibrillation therapies with patient-reported outcomes.
  Gleason, K. T.,Dennison Himmelfarb, C. R.,Ford, D. E.,Lehmann, H.,Samuel, L.,Jain, S.,Naccarelli, G.,Aggarwal, V.,Nazarian, S.> ;Heart. 2019 May 24
• Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.
  DaJuanicia N. Holmes, Jonathan P. Piccini, Larry A. Allen, Gregg C. Fonarow, Bernard J. Gersh, Peter R. Kowey, Emily C. O’Brien, James A. Reiffel, Gerald V. Naccarelli...> ;Circulation-cardiovascular Quality and Outcomes. 2019 May 1
• Association of sex, age and education level with patient reported outcomes in atrial fibrillation.
  Kelly T. Gleason, Cheryl Dennison Himmelfarb, Daniel E. Ford, Harold P Lehmann, Laura Samuel, Hae Ra Han, Sandeep Jain, Gerald V. Naccarelli, Vikas Aggarwal, Saman Naz...> ;BMC Cardiovascular Disorders. 2019 Apr 5
• Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Rando...
  Douglas L. Packer, Daniel B. Mark, Richard A. Robb, Kristi H. Monahan, Tristram D. Bahnson, Jeanne E. Poole, Peter A. Noseworthy, Yves Rosenberg, Neal Jeffries, L. Bre...> ;JAMA. 2019 Apr 2
• Antiarrhythmic Drugs for Atrial Fibrillation in the Real World: Trick or Treat.
  Gerald V. Naccarelli> ;JACC: Clinical Electrophysiology. 2019 Feb 1
• Screening for Atrial Fibrillation Comes With Many Snags
  John Mandrola, Andrew Foy, Gerald V. Naccarelli> ;JAMA Internal Medicine. 2018 Oct 1
• B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.
  Inohara, T., Kim, S., Pieper, K., Blanco, R. G., Allen, L. A., Fonarow, G. C., Gersh, B. J., Ezekowitz, M. D., Kowey, P. R., Reiffel, J. A., Naccarelli, G. V., Chan, P...> ;Heart (British Cardiac Society). 2018 Sep 20
• Cardiac automaticity: basic concepts and clinical observations.
  Vetulli, H. M., Elizari, M. V., Naccarelli, G. V., Gonzalez, M. D.> ;Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2018 Aug 17
• Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation.
  Ilir Maraj, Mario D. Gonzalez, Gerald V. Naccarelli> ;The Journal of innovations in cardiac rhythm management. 2018 Aug 1
• Can an Intranasal Calcium-Channel Blocker Convert Paroxysmal Supraventricular Tachycardia and Keep the Doctor Away?
  Naccarelli, G. V., Wolbrette, D. L., Gonzalez, M. D.> ;Journal of the American College of Cardiology. 2018 Jul 28
• A Quarter of a Century Later: What is Dofetilide's Clinical Role Today?
  Wolbrette, D. L., Hussain, S. K., Maraj, I., Naccarelli, G. V.> ;Journal of cardiovascular pharmacology and therapeutics. 2018 Jun 27
• Join now to see all

Lectures

• Direct Oral Anticoagulant Dosing Truth or Consequences 
  Penn State Hershey College of Medicine - Continuing Education, Harrisburg, Pennsylvania - 10/3/2013
• Antiarrhythmic Drugs Are A Lost Cause 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Electrophysiology Expert 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Can an Intranasal Calcium-Channel Blocker Convert Paroxysmal Supraventricular Tachycardia and Keep the Doctor Away? 
  Penn State Hershey College of Medicine - Continuing Education, Harrisburg, Pennsylvania - 10/3/2013
• Join now to see all